? ADMINISTRATIVE CORE The Rush Alzheimer's Disease Core Center (Rush ADCC) Administrative Core is the mechanism for providing scientific leadership for the ADCC. It coordinates the activities of the Cores and pilot projects, facilitates communication among the investigators, provides for efficient allocation of resources, and oversees data and resource sharing activities. The responsibility for overall scientific leadership will rest with Dr. Bennett as ADCC Director and is shared with and exercised through the Executive Committee composed of the Core Leaders, Administrator, Data Manager, a non-ADCC Core Leader, and non-ADCC ad hoc members that have staggered rotations. Four other committees carry out specific functions. The External Advisory Committee, composed of distinguished investigators active in AD research at institutions outside the Chicago area, assesses Rush ADCC progress and provides advice concerning the directions ADCC efforts should take. The Resource Distribution Committee evaluates all requests for data, requests for access to participants for recruitment into externally-funded studies, and for ante-mortem and post-mortem specimens from persons evaluated by the Clinical and Religious Orders Study Cores, and advises the Director and Executive Committee concerning priorities in distributing these resources. The Administrative Core places strong emphasis on facilitating wide access to ADCC data and tissue resources, while assuring that only scientifically sound investigations will receive this access, resolving issues related to competing uses for limited specimens, and avoiding wasteful overlap in effort. The Pilot Project Committee conducts the competitive review of all pilot project proposals submitted to the ADCC. A major criterion for success of each pilot project is whether it will likely lead to a fully developed, scientifically excellent study that secures independent funding. A new Research Education Committee will evaluate applications for mini-internships and structured mentoring by Rush ADCC and other personnel.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010161-30
Application #
9977084
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
30
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Yu, Lei; Petyuk, Vladislav A; Gaiteri, Chris et al. (2018) Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol 84:78-88
Jansen, Willemijn J; Wilson, Robert S; Visser, Pieter Jelle et al. (2018) Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging 61:138-145
Benedet, Andréa L; Yu, Lei; Labbe, Aurélie et al. (2018) CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem. Neurol Genet 4:e216
Tan, Chin Hong; Fan, Chun Chieh; Mormino, Elizabeth C et al. (2018) Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol 135:85-93
Arvanitakis, Zoe; Leurgans, Sue E; Fleischman, Debra A et al. (2018) Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol 83:718-729
Blue, Elizabeth E; Bis, Joshua C; Dorschner, Michael O et al. (2018) Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. Dement Geriatr Cogn Disord 45:1-17
Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha et al. (2018) Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. Alzheimer Dis Assoc Disord 32:1-9
Wilson, Robert S; Capuano, Ana W; Yu, Lei et al. (2018) Neurodegenerative disease and cognitive retest learning. Neurobiol Aging 66:122-130
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021

Showing the most recent 10 out of 786 publications